Indaptus Therapeutics Stock Forecast - Naive Prediction

INDP Stock  USD 2.12  0.06  2.75%   
The Naive Prediction forecasted value of Indaptus Therapeutics on the next trading day is expected to be 2.11 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 4.15. Indaptus Stock Forecast is based on your current time horizon. Although Indaptus Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Indaptus Therapeutics' systematic risk associated with finding meaningful patterns of Indaptus Therapeutics fundamentals over time.
As of 07/24/2024, Payables Turnover is likely to drop to 0. As of 07/24/2024, Common Stock Shares Outstanding is likely to drop to about 4.8 M. In addition to that, Net Loss is likely to grow to about (12.2 M).
Most investors in Indaptus Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Indaptus Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Indaptus Therapeutics' price structures and extracts relationships that further increase the accuracy of the generated results.
First Reported
Previous Quarter
13.4 M
Current Value
16.1 M
Quarterly Volatility
8.2 M
Credit Downgrade
Yuan Drop
A naive forecasting model for Indaptus Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Indaptus Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Indaptus Therapeutics Naive Prediction Price Forecast For the 25th of July

Given 90 days horizon, the Naive Prediction forecasted value of Indaptus Therapeutics on the next trading day is expected to be 2.11 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.15.
Please note that although there have been many attempts to predict Indaptus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Indaptus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Indaptus Therapeutics Stock Forecast Pattern

Backtest Indaptus TherapeuticsIndaptus Therapeutics Price PredictionBuy or Sell Advice 

Indaptus Therapeutics Forecasted Value

In the context of forecasting Indaptus Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Indaptus Therapeutics' downside and upside margins for the forecasting period are 0.02 and 7.00, respectively. We have considered Indaptus Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
Expected Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Indaptus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Indaptus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.2622
BiasArithmetic mean of the errors None
MADMean absolute deviation0.068
MAPEMean absolute percentage error0.0287
SAESum of the absolute errors4.1502
This model is not at all useful as a medium-long range forecasting tool of Indaptus Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Indaptus Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Indaptus Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Indaptus Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Indaptus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
2 Analysts
Estimates (0)
LowProjected EPSHigh

Other Forecasting Options for Indaptus Therapeutics

For every potential investor in Indaptus, whether a beginner or expert, Indaptus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Indaptus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Indaptus. Basic forecasting techniques help filter out the noise by identifying Indaptus Therapeutics' price trends.

Indaptus Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Indaptus Therapeutics stock to make a market-neutral strategy. Peer analysis of Indaptus Therapeutics could also be used in its relative valuation, which is a method of valuing Indaptus Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Indaptus Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Indaptus Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Indaptus Therapeutics' current price.

Indaptus Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Indaptus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Indaptus Therapeutics shares will generate the highest return on investment. By undertsting and applying Indaptus Therapeutics stock market strength indicators, traders can identify Indaptus Therapeutics entry and exit signals to maximize returns.

Indaptus Therapeutics Risk Indicators

The analysis of Indaptus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Indaptus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting indaptus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Indaptus Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Indaptus Stock

  0.44GILD Gilead SciencesPairCorr
  0.33KAKZF Kaspi Bank JointPairCorr
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.